AbbVie Inc (ABBV) Stock Analysis
AbbVie Inc trades on the NYSE under the ticker ABBV. StonkBuddy files it under Healthcare. It is in the S&P 500.
ABBV price context
- 52-week range: $190.75 to $291.40 (as of October 23, 2026)
- Market value: about $499.53 billion (October 19, 2026)
Next earnings
AbbVie Inc is expected to report results on October 30, 2026, before the market opens. Earnings calendar
Congress trades in ABBV
In the last 12 months, members of Congress reported 9 trades in ABBV (House and Senate disclosure reports). The latest reported:
- Pete Sessions: Sold, $15,001 - $50,000, traded September 14, 2026, reported September 18, 2026 (filing)
- Josh Gottheimer: Sold, $1,001 - $15,000, traded May 5, 2026, reported June 3, 2026 (filing)
- Alan Armstrong: Bought, $15,001 - $50,000, traded March 27, 2026, reported July 21, 2026 (filing)
- Julie Johnson: Sold, $1,001 - $15,000, traded December 18, 2025, reported January 15, 2026 (filing)
- Julia Letlow: Sold, $1,001 - $15,000, traded December 8, 2025, reported January 13, 2026 (filing)
All Congress trades · Filed this week
Compare ABBV
Members also see the StonkBuddy score for ABBV on this page. What the score means